AbCellera Biologics Inc. (ABCL) vs Dianthus Therapeutics, Inc. (DNTH)
- AbCellera Biologics Inc. ABCL 11.80 −6.94%
- Dianthus Therapeutics, Inc. DNTH 72.09 −3.27%
AbCellera Biologics Inc. and Dianthus Therapeutics, Inc. are both Biotechnology companies. AbCellera Biologics Inc. and Dianthus Therapeutics, Inc. are of similar size ($4.2B and $4.1B). AbCellera Biologics Inc. grew revenue faster over the last twelve months: 101.3% against −60.8%. AbCellera Biologics Inc. has the higher net margin (−248.8% vs −10,097.0%) and the higher return on invested capital (−42.5% vs −47.7%). Across the 15 metrics below, AbCellera Biologics Inc. leads on 12 and Dianthus Therapeutics, Inc. on 3.
Valuation
Profitability
| Metric | ABCL | DNTH | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 65.16% |
| Operating margin | (340.25%) | (11,441.39%) | 0.00% |
| Net margin | (248.82%) | (10,096.95%) | 0.00% |
| Free cash flow margin | (180.84%) | (8,177.99%) | 0.00% |
| Return on equity | (17.30%) | (26.07%) | (56.36%) |
| Return on assets | (12.15%) | (24.98%) | (48.04%) |
| Return on invested capital | (42.52%) | (47.74%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack